Barclays
AMRN

Barclays’s Amarin Corp AMRN Stock Holding History

Barclays’s Portfolio AMRN Stock Details AMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-515
Closed -$35K – 4915
2021
Q4 		$35K Hold
515
– – ﹤0.01% 3883
2021
Q3 		$53K Hold
515
– – ﹤0.01% 4091
2021
Q2 		$45K Hold
515
– – ﹤0.01% 4175
2021
Q1 		$64K Sell
515
-15,440
-97% -$2.08M ﹤0.01% 4146
2020
Q4 		$1.56M Hold
15,955
– – ﹤0.01% 2436
2020
Q3 		$1.34M Sell
15,955
-1,520
-9% -$182K ﹤0.01% 2436
2020
Q2 		$2.42M Sell
17,475
-35,540
-67% -$4.89M ﹤0.01% 1937
2020
Q1 		$4.24M Buy
53,015
+36,565
+222% +$12.1M ﹤0.01% 1610
2019
Q4 		$7.05M Sell
16,450
-15,170
-48% -$5.76M ﹤0.01% 1676
2019
Q3 		$9.59M Sell
31,620
-840
-3% -$293K 0.01% 1310
2019
Q2 		$12.6M Buy
32,460
+12,120
+60% +$4.44M 0.01% 1213
2019
Q1 		$8.45M Sell
20,340
-27,995
-58% -$10.1M 0.01% 1327
2018
Q4 		$13.2M Sell
48,335
-61,825
-56% -$22.5M 0.01% 996
2018
Q3 		$35.8M Buy
110,160
+109,110
+10,391% +$8.24M 0.02% 560
2018
Q2 		$65K Sell
1,050
-4,410
-81% -$273K ﹤0.01% 5500
2018
Q1 		$329K Sell
5,460
-1,235
-18% -$91.7K ﹤0.01% 4376
2017
Q4 		$537K Buy
6,695
+4,530
+209% +$312K ﹤0.01% 3750
2017
Q3 		$152K Buy
2,165
+1,505
+228% +$107K ﹤0.01% 4632
2017
Q2 		$53K Buy
660
+410
+164% +$25.5K ﹤0.01% 5322
2017
Q1 		$16K Sell
250
-4,585
-95% -$291K ﹤0.01% 5888
2016
Q4 		$298K Sell
4,835
-1,005
-17% -$63.9K ﹤0.01% 3842
2016
Q3 		$373K Buy
5,840
+1,635
+39% +$91.6K ﹤0.01% 3474
2016
Q2 		$182K Sell
4,205
-21,625
-84% -$813K ﹤0.01% 3980
2016
Q1 		$517K Buy
25,830
+22,320
+636% +$663K ﹤0.01% 3120
2015
Q4 		$70K Sell
3,510
-75
-2% -$2.94K ﹤0.01% 4608
2015
Q3 		$72K Buy
3,585
+300
+9% +$13.6K ﹤0.01% 4808
2015
Q2 		$131K Buy
3,285
+1,575
+92% +$70.9K ﹤0.01% 4455
2015
Q1 		$68K Buy
+1,710
New +$52.2K ﹤0.01% 5085
2014
Q4 		– Sell
-2,020
Closed -$40K – 7239
2014
Q3 		$40K Sell
2,020
-6,790
-77% -$221K ﹤0.01% 6045
2014
Q2 		$176K Sell
8,810
-2,830
-24% -$88.8K ﹤0.01% 4934
2014
Q1 		$233K Sell
11,640
-1,280
-10% -$47.6K ﹤0.01% 4637
2013
Q4 		$259K Sell
12,920
-135,060
-91% -$6.99M ﹤0.01% 4759
2013
Q3 		$17.8M Buy
147,980
+117,485
+385% +$14.1M 0.02% 735
2013
Q2 		$3.54M Buy
+30,495
New +$4.21M ﹤0.01% 1931

Other funds holding AMRN

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WW
Waterfront Wealth Overland Park, Kansas $545M AUM 19.05% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Barclays's AMRN Position: Q4 2025 in Review

Barclays sold out of Amarin Corp (AMRN) in Q4 2025, closing a stake of 2,242 shares — an estimated $36.7K sold.

Barclays first reported a position in AMRN in Q2 2013 and held it in 50 quarters. The position peaked at $19.1M in Q4 2019. 82 funds tracked by Wall St. Rank hold AMRN as of Q4 2025.

  • Barclays reported no remaining Amarin Corp position as of Q4 2025 after selling out during the quarter.
  • Barclays sold 2,242 Amarin Corp shares in Q4 2025, an estimated $36.7K.
  • Barclays first reported a position in Amarin Corp in Q2 2013 and held it in 50 quarters.
  • Barclays's Amarin Corp position peaked at $19.1M in Q4 2019.
  • 82 funds tracked by Wall St. Rank held Amarin Corp as of Q4 2025.

Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.